PRJNA729588
Deep Whole-Genome Sequencing Reveals No Evidence for Heteroresistance Influencing Treatment Outcomes Among Drug-Susceptible Tuberculosis Patients
We used whole-genome sequencing to analyze heteroresistance among drug-susceptible new and retreated tuberculosis patients and found no evidence that heteroresistance < 1% is associated with poor treatment outcomes.